Advanced Search
SCHEDULE 1
Page 5 of 29
Previous Next
First page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Last page
Regulation 4(3)
PART 1
Application for a marketing authorisation
1. Application for a marketing authorisation
2. Information with the application
3. Summary of product characteristics
4. Supply of a copy of the summary of product characteristics
5. Time limits for applications for products for use in food-producing animals
PART 2
Derogations from some of the requirements in Part 1
6. Scope
7. Bibliographic application
8. Application for a product using a new combination of active substances
9. Application using existing data
10. Application for a pharmacologically equivalent medicinal product
11. Time limits for marketing authorisations granted under the procedure for a pharmacologically equivalent product
12. Extension of time limits
13. Parallel imports
14. Specific batch control scheme
15. Similar immunological products
16. Marketing in exceptional circumstances
PART 3
Grant of a marketing authorisation
17. Time limits
18. Place of establishment of applicant
19. Procedure
20. Products authorised in another member State
21. Assessment reports
22. Grant of a marketing authorisation
23. Marketing authorisations for food-producing species
24. Refusal of a marketing authorisation
25. Publication following the grant of a marketing authorisation
26. Provisional marketing authorisation
27. Provisions of samples and expertise
28. Supply of information
29. Duties on the holder of a marketing authorisation relating to an immunological product
30. Control tests
31. Placing on the market
32. Duration and validity of a marketing authorisation
PART 4
Variations of marketing authorisations on the application of the holder
33. Variation of a marketing authorisation for a mutually recognised veterinary medicinal product
34. Variation of a marketing authorisation not authorised in another member State
35. Administrative variations
36. Changes after a marketing authorisation has been issued
37. Compulsory variation
PART 5
Suspension, etc. of a marketing authorisation
38. Suspension of a marketing authorisation: grounds
39. Suspension of a marketing authorisation: procedure
40. Revocation
41. Prohibiting the supply of veterinary medicinal products
PART 6
Mutual recognition and multiple applications
42. Application for a marketing authorisation where one already exists in another member State
43. Application in another member State
44. Application for a marketing authorisation in multiple member States where a marketing authorisation does not exist in any member State
PART 7
Labelling and package leaflets
45. Approval by the Secretary of State
46. Reference to being authorised
47. Language
48. Labelling with all the information on the immediate packaging
49. Products with immediate and outer packaging
50. Package leaflets
51. Ampoules
52. Small containers other than ampoules
53. Homeopathic remedies
54. Variations
PART 8
Pharmacovigilance
55. Qualified persons responsible for pharmacovigilance
56. Duties relating to the qualified person
57. Adverse reactions to a veterinary medicinal product administered in the United Kingdom
58. Adverse reactions to a veterinary medicinal product administered in a third country
59. Periodic safety update reports
60. Release of information by the marketing authorisation holder
61. Action taken on account of pharmacovigilance
PART 9
Homeopathic remedies
62. Meaning of “homeopathic remedy”
63. Placing a homeopathic remedy on the market in accordance with a registration
64. Application for registration
65. Procedure for registration
66. Products on the market before 1994
67. Classification
[Contact Us] [Freedom of Information] [Complaints] [Crown copyright] [Privacy policy]